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 ABSTRACT 
 
Introduction 
Frailty is a recognised predictor of poor outcome in patients undergoing surgical 
intervention. Frailty is intricately linked with body morphology, which can be 
evaluated using morphometric assessment via computerised tomographic (CT) 
imaging.  We aimed to assess the predictive power of such objective assessments in a 
broad cohort of vascular surgical patients. 
 
Patients and methods 
A consecutive series of patients aged over 65 years admitted to a vascular unit, who 
had undergone CT imaging of the abdomen, were analysed.  
Demographic and patient specific data was collated alongside admission relevant 
information. Outcomes included mortality, length of stay, healthcare related costs and 
discharge destination. Images were analysed for four morphometric measurements: i) 
psoas muscle area, ii) mean psoas density, iii) subcutaneous fat depth and iv) intra-
abdominal fat depth, all taken at the level of the fourth lumbar vertebra.  
 
Results 
Two hundred and ten patients were initially analysed.  Forty four patients had 
significant retroperitoneal and abdominal abnormalities that limited appropriate CT 
analysis.  Decreased subcutaneous fat depth was significantly associated with 
mortality, readmission within 12 months and increased cost of healthcare (P < 0.01 – 
adjusted for confounders).  Psoas muscle area was significantly associated with 
readmission-free survival.  
 
Conclusions 
Morphometric analysis predicts poorer outcome in a broad cohort of vascular surgery 
patients. Such assessment is likely to enhance patient counselling regarding individual 
risk as well as enhancing the ability to undertake risk modified surgical audit. 
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INTRODUCTION 
 
The population worldwide is aging, with this observed trend of an aging population 
predicted to continue over the next 20 years1,2. For example, the proportion of people 
over the age of 85 years within the UK set to increase by 109%, compared to a 7% 
increase in the population of 15-64 year olds1. These predicted population statistics 
will have major impact upon healthcare provision and associated socioeconomic 
costs. Indeed, although current life expectancy has increased, this has not been 
associated with a decline in mild to moderate disability rates2, which is in part likely 
due to an increased burden of multiple chronic diseases. 
 
Ageing is defined as the accumulation of changes in a human being over time3. This 
encompasses physical changes, a result of damage at a molecular and cellular level, 
psychological and social changes. However, these changes are neither linear with 
increasing age nor consistent between two people of the same age. 
Vascular disease has a strong association with age. This is common to all territories, 
including the arterial and venous systems. Indeed, more than 20% of patients aged 80-
89 and 30% of patients aged 90-99 have disease in at least one vascular territory4. As 
the population ages, this will cause a corresponding increase in demand for vascular 
surgical intervention. Allied to this, continued improvements in minimally invasive 
technology means that more older patients have the potential to be treated.  
 
Frailty is a phenotype often seen within the older population. It is characterised by 
reduced homeostatic reserves, leading to increasing vulnerability. It increases risk for 
hospitalisation, falls, disability and mortality5 and previous studies have shown 
increasing frailty predicts poorer outcome in surgical patients6,7,8,9,10. 
 
Morphometric measures have long been used to predict outcomes in surgery11,12,13, 
and the increasing role of cross sectional imaging within secondary care increases the 
availability of such data. Yet the evidence with regard to such factors is limited, 
specifically within the high-risk group of vascular surgical patients. 
 
As such, the aim of this study was to determine whether standard morphometric data 
was able to predict short and mid term patient related adverse outcomes in older 
vascular surgical patients, with a primary outcome of survival during follow-up and 
secondary outcomes including length of in-hospital stay, discharge destination and 
readmission-free survival. 
  
METHODS 
 
All patients admitted between 1 January 2012 and 31 December 2012 to the 
Cambridge Vascular Unit were screened for inclusion.  The cohort of patients 
analysed was a subset of a database previously described by our group11.  In addition 
to the inclusion criteria of age at least 65 years and length of hospital stay two or more 
days, which were used in previous work, we also included only those patients who 
had had a computerised tomographic (CT) scan of the abdomen either during the 
index admission or within the previous six months from the date of admission.  
Patients were included irrespective of whether they underwent a surgical procedure or 
not. Patients were followed up until 31st December 2013 with no deviation from 
standard follow up requirements which varied for each patient. No data was collected 
after the 31st December 2013.  Data available included basic demographic 
information, mode of admission, diagnosis, management, prolonged length of stay 
(defined as greater than or equal to one week), discharge destination (whether to the 
patient’s own home, a nursing/residential home, or another hospital), mortality and 
readmissions (including readmission to the base hospital and other hospitals within 
the vascular network).  In addition we measured various frailty-specific factors 
detailed previously11. These included age, sex, independent mobility on admission, 
living alone, Katz score, Charlson comorbidity index, Waterlow score, history of 
depression, previous admission to intensive care, primary admission diagnosis, 
number of medications on admission, visual or hearing impairment, cognitive 
impairment on admission, history of two or more falls in the past 12 months, anaemia, 
evidence of malnutrition, and whether the admission was planned or emergent. The 
hospital electronic records system is linked to the United Kingdom Office for 
National Statistics for collection of mortality data. Data were collected as part of 
routine service evaluation and no patient identifiable data are presented, so it was not 
deemed necessary to seek ethical approval or retrospective consent for the study. 
 
Morphometric analysis 
 
CT images of the abdomen and pelvis were evaluated using GE Life SciencesTM 
workstations. Morphometric measurements were made independently by two 
operators (NAZ and AWa), and the results averaged to improve accuracy.   
Four measurements were determined for this study: psoas muscle area (PMA, mm2) 
psoas muscle mean density (PMD, measured in Hounsfield units – Figure 1), 
subcutaneous fat depth (SCF, mm) and intra-abdominal fat depth (IAF, mm – Figure 
2).   
 
Axial cross-sectional areas and densities of the left and right psoas muscles on axial 
section at mid fourth lumbar vertebra (L4) level were processed using multi-planar 
reconstruction (MPR). Outlines of the psoas muscles were traced using the area 
calculation tool and densities were measured within the traced area using the region-
of-interest (ROI) tool. Fat thickness values were measured using the distance tool. 
Subcutaneous fat depth measurements were made from the anterior abdominal wall 
fascia to the skin, and IAF was measured from the L4 anterior vertebral body to the 
anterior abdominal wall fascia. Patients with significant retroperitoneal or abdominal 
abnormalities on the reference CT were excluded owing to the difficulty in accurately 
assessing psoas area and density. 
 
Statistical analysis 
 
Analysis was performed using R statistical software version 3.1.1 (http://www.r-
project.org/foundation).  The association between the four morphometric 
measurements and the primary and secondary outcomes were assessed using both 
univariate analysis and also multivariate analysis to allow correction for potential 
confounders.  For univariate analysis we used the Mann-Whitney U test for prolonged 
length of stay and discharge destination, and the log-rank test for survival and 
readmission-free survival.  Confounder adjustment was performed by allowing all 
measured covariates to be present in multivariate models and using stepwise 
minimisation of Akaike’s Information Criterion14 to prevent overfitting.  Measured 
covariates were age, sex, independent mobility on admission, living alone, Katz score, 
Charlson comorbidity index, Waterlow score, history of depression, previous 
admission to intensive care, primary admission diagnosis, number of medications on 
admission, visual or hearing impairment, cognitive impairment on admission, history 
of two or more falls in the past 12 months, anaemia, evidence of malnutrition, and 
whether the admission was planned or emergent which have all been defined 
previously 11.  Prolonged length of stay and discharge destination were modelled 
using logistic regression15, whereas survival and readmission-free survival was 
modelled using Cox’ proportional hazards16. Correlation was determined using the 
Spearman’s Rank Correlation17. 
 
  
RESULTS 
 
Between January 1st and December 31st 2012, 823 patients were admitted to the 
Vascular Unit, of whom 210 satisfied the three inclusion criteria of age, duration of 
admission and availability of CT imaging.  The median age was 76 (range 65-94), and 
follow-up was for a median of 18 months (range 12-24).  One hundred and fifty seven 
were male, and 53 were female with 87 being emergency admissions.  
Thirty-one patients died within 12 months of admission, and a further seven died 
during the second year of follow-up. Eight deaths were on the index admission. The 
median length of stay was 6 days (range 2-93). The overall median readmission free 
survival was 318 days (range 1-669). 
 
In 44 of the patients, abdominal CT was unsuitable for morphometric measurements 
due to significant abnormalities. These abnormalities precluded assessment of the 
psoas muscle and as such this cohort were excluded from subsequent analysis 
resulting in a final cohort of 166 patients.  Reasons for CT related exclusions included 
inflammatory intra-abdominal conditions and retroperitoneal haematoma (often 
related to ruptured abdominal aortic aneurysms), making it impossible to accurately 
record the size and density of the psoas muscle.  
Of the 166 patients, 48 were female and the median age was 76 years with 64 patients 
being emergency admission. Median length of stay was 11 days (range 2-74 days). 
The admitting diagnosis for the 144 patients were as follows: 9 patients with lower 
limb ulceration, 41 patients with chronic lower limb ischaemia, 6 patients with acute 
lower limb ischaemia, 74 patients with AAA treated with EVAR, 15 patients with 
AAA treated with open repair and 21 patients with other miscellaneous diagnoses. 
Surgical interventions were as follows, EVAR 75, open AAA repair 15, major lower 
limb amputation 5, infrainguinal lower limb bypass 20, common femoral 
endarterectomy 5 and lower limb embolectomy in 4. The remaining 42 patients 
underwent diagnostic / conservative management. The frailty specific factors are 
tabulated in table 1. The overall median readmission free survival was 315 days.  
Morphometric analysis 
Overall values for the PMA, PMD, SCF and IAF are shown in Table 2.  
 
Increased SCF depth was a significant predictor of survival in this cohort of patients 
(P < 0.001 – Table 3), and this association persisted after adjustment for confounders 
(P < 0.01 – Table 4).  After adjustment for overfitting, significant confounders for 
survival were patient age, Katz score, Charlson comorbidity index, Waterlow score, 
emergent admission, frequent falls (at least 2 in the past 12 months), a history of 
depression, and hearing impairment. When the SCF depth was split into quartiles the 
lowest quartile was associated with the poorest outcome (P < 0.001 – Figure 3).  
Median values of SCF for the four quartiles (Q1 – Q4) were 11, 15, 20 and 28 mm 
respectively.  None of the remaining three morphometric measurements were 
significantly associated with survival. 
 
Increased SCF depth was also associated with improved readmission-free survival (P 
= 0.04 – Table 3), as was reduced average psoas muscle area (P = 0.04 – Table 3), and 
these associations also persisted following adjustment for confounding variables (P = 
0.004 and P = 0.02 respectively – Table 4).  After adjustment for overfitting, 
significant confounders for readmission-free survival were patient sex, Katz score, 
admission for a limb-related problem, and independent mobility on admission.  No 
morphometric measurements were associated with either prolonged length of stay or 
discharge to a care facility.   
 
Decreased SCF depth was also implicated in increased cost of healthcare (P < 0.01), 
remaining significant after adjustment for confounders.  After adjustment for 
overfitting, significant confounders for cost of healthcare were patient sex, Katz 
score, Waterlow score, emergent admission, primary admission diagnosis, previous 
admission to intensive care, visual or hearing impairment and evidence of 
malnutrition on admission. None of the morphometric measurements were associated 
with prolonged LOS or discharge destination. 
 
When assessing correlations between the morphometric factors assessed we found a 
positive correlation between psoas muscle area and intra-abdominal fat depth and a 
weak negative correlation between psoas muscle mean density and intra-abdominal 
fat depth (Table 5). 
  
DISCUSSION 
 
The data from this study suggests that vascular surgery patients with lower levels of 
subcutaneous fat have an increased mortality rate, lower readmission free survival 
rates with associated increased associated healthcare costs. Over the last one to two 
decades body composition has been increasingly investigated and shown to predict 
outcome in numerous patient groups. Data such as presented here is thus increasingly 
relevant to vascular surgery as the population continues to age.  
It is well recognised that as aging progresses there is age-related fat redistribution 
with a reduction in subcutaneous fat mass yet an associated increase in overall fat 
mass18. Traditional teaching has suggested that obesity is a predictor of poor outcome 
in general yet, the “obesity paradox”,  a somewhat counterintuitive medical 
hypothesis, suggests that obesity may actually be protective with associated increased 
survival specifically in older patients and patients with chronic diseases such as renal 
and cardiac failure19,20,21. Such a phenomenon is seen within vascular surgery patients 
as a whole22,23,24 and specifically in lower limb surgical and endovascular 
revascularisation25,26 and carotid surgery27, although not in aneurysm surgery28,29,30. 
While body mass index is suitable for population-based studies, it has well recognised 
limitations when assessing individual patients including poor differentiation between 
fat and muscle and an inability to determine fat distribution (e.g. central vs 
peripheral). Morphometric analysis is able to analyse body composition in part due to 
increasingly widespread used of computerised tomography (CT) in the diagnosis and 
follow up of surgical patients. Such techniques have been well validated within the 
surgical literature37.  
The majority of such data is in patients undergoing abdominal surgery including 
surgery for intra-abdominal malignancy. Fat distribution has been shown to predict 
poorer outcomes with fat composition predicting infective complications post Crohn’s 
resection as well as following midline laparotomy31,32. Psoas muscle characteristics 
predict both survival, length of stay and complication rates in a number of patients 
groups33 undergoing abdominal surgery34,35. Specifically, sarcopenia is associated 
with higher healthcare costs36,37. Potential links between sarcopenia and potential 
overall function in older, more vulnerable patients have been examined and one study 
found that psoas characteristics predicted reduced mobility, poorer functional 
performance with allied cognitive impairment in this specific cohort of patients 38.  
 
Sarcopenia is the loss of skeletal muscle mass and strength as a result of ageing and 
morphometric analysis allows quantitative evaluation specifically of muscle 
composition.  As such, morphometric analysis has been increasingly used to 
determine both skeletal muscle mass as well as fat distribution using CT scans as the 
primary imaging technique14,15,16,39.  
Sarcopenia specific studies (as apposed to BMI related studies) on vascular surgical 
patients are somewhat sparse. One study published by Matsurbara et al suggested that 
a binary diagnosis of sarcopenia (defined using muscle mass) predicted longer-term 
mortality in patients with critical limb ischaemia40. A further study by Lee et al 
specifically analysed a cohort of patients undergoing abdominal aortic aneurysm 
(AAA) repair. They found that there was a significant association between psoas 
muscle area and postoperative mortality in a cohort of 262 patients with a mean 
follow up of 2.3 years41. This study is the first to examine such characteristics in a 
broader vascular surgical cohort representative of everyday practice and given the 
association in elderly patients, we specifically analysed patients over the age of 65 
years.   
The sarcopenia specific results from our study (reduced PSA associated with 
increased readmission free survival) do not reflect the data from previous studies.  
This may be due to the more heterogeneous group of patients analysed (ie. not 
procedure of diagnosis specific) or may be location specific (a “healthier” set of 
patients) but these require further exploration.  
 
There are recognised limitations and possible areas of bias within this type of study. 
Primarily this relates to the types of patients undergoing CT examination. Firstly the 
study cohort was naturally restricted to those patients who had undergone a CT scan, 
generally endovascular / open aortic repair and patients requiring more 
comprehensive imaging prior to lower limb revascularization, yet this is reflective of 
“real world” care. Furthermore, not all CT examinations were suitable for inclusion – 
namely those patients with a ruptured AAA or large AAA’s that distort the outline of 
the psoas muscle. Exclusion criteria were as per a previously published study and 
were determined so as to exclude patients admitted overnight for observation after 
minor procedures such as angioplasty or varicose vein procedures.  The definition of 
prolonged LOS as greater than or equal to one week, irrespective of diagnosis, was 
chosen firstly as the median LOS within the whole patient cohort was 6 days, and 
secondly as this was considered to be more than would be expected for the majority of 
admissions. Similarly, we performed little subgroups analysis, specifically with 
regard to admission diagnosis, as the number of patients in each group was too small 
to make sound statistical analysis. Readmission was felt to be an appropriate outcome 
measure as geriatric syndromes are well recognised cause of readmission which are 
also associated with increased morbidity and higher costs and given the inclusion 
criteria, such readmission were likely to be significant. Finally, while this study 
suggests association between these morphometric findings and outcome it does not 
show causality which requires more complex prospective longitudinal investigation. 
 
The unique factors associated with an aging population means that there is a need for 
reliable quantification of operative and non-operative risk specifically with regard to 
enhancing our ability to predict both morbidity and mortality. Frailty itself is without 
an all-encompassing definition and there is no single “gold standard” test. The 
retrospective nature of this study has limited a comparison between various measures 
of frailty. CT examination is becoming a more frequent medical investigation and it is 
likely that although morphometric analysis on its own will not be the panacea when 
determining patient outcome it is more likely to be used as part of a battery of 
assessments that will ultimately predict short and longer term outcome. This will need 
further assessment using large prospectively collated databases. Furthermore, it may 
be that some of these predictors can be positively modified either prior to or on 
admission to improve outcome and as such this study ultimately strengthens the 
evidence for the need of in hospital multidisciplinary teams to address frailty 
incorporating medical, nursing and allied health professionals. Finally, such markers 
of sarcopenia may allow for appropriate patient counselling about individual risk yet 
again prospective studies are required to confirm general applicability but further data 
may strengthen surgical audit given the increasing drive towards publication of 
surgeon-specific outcomes.  
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Figure 1. Psoas muscle area and mean density measurements using GE-SolutionsTM 
workstation volume-viewer. At the level of L4 vertebral body, an area marker is 
drawn around the borders of the psoas muscle which represents the psoas area in 
mm2. A region of interest (ROI) is marked inside the psoas area which represents the 
average density of the psoas muscle area in Hounsfield Units (HU). 
 
 
                                                                                                                                                        
 
Figure 2. Subcutaneous and intra-abdominal fat measurement using GE-SolutionsTM 
workstation volume-viewer. At the level of L4 vertebral body, a measurement line is 
drawn from the anterior abdominal skin surface to the linea alba which represents 
subcutaneous fat thickness in mm. A second line is drawn from the linea alba to the 
anterior surface of the vertebral body which represents intra-abdominal fat thickness 
in mm. 
 
 
                                                                                                                                                        
  
 
Figure 3. Kaplan-Meier survival curves for quartiles of subcutaneous fat depth.  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLES 
                                                                                                                                                        
 
 
Frailty specific factor (n=166)  
Independent on admission* 128 
Living alone* 52 
Katz score 6 (6-6) 
Charlson morbidity index 2 (1-4) 
Waterlow score on admission 12 (9-15) 
Depression* 13 
Number of medication on admission 7 (1-10.75) 
Visual impairment* 12 
Hearing impairment* 15 
Cognitive impairment* 6 
Haemaglobin 12 (10.5 - 13.6) 
Malnutrition* 19 
More than 2 falls within the preceding 
12 months* 
17 
Table 1: Frailty specific factors analysed in the cohort of 166 patients with a Ct 
deemed suitable for morphometric analysis. * number of patients. Other values are 
median and interquartile range. Appropriate definitions of each factor can be found at 
reference 11.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Median Interquartile range 
                                                                                                                                                        
Subcutaneous fat depth 
(mm) 
17.5 12.8 – 22.7 
Intra-abdominal fat depth 
(mm) 
108 88.5 – 133.2 
Psoas muscle area (mm2) 2253 1836 – 2717 
Mean psoas density (HU) 41.7 37.7 – 45.8 
 
Table 2. Median and interquartile ranges for the four morphometric measurements.  
HU: Hounsfield Units. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Survival Readmission-
free survival 
Prolonged 
LOS 
Discharge 
to Care 
Subcutaneous 
fat 
0.0008 0.04 0.96 0.55 
                                                                                                                                                        
Intra-
abdominal fat 
0.30 0.33 0.26 0.15 
Psoas muscle 
area 
0.27 0.04 0.39 0.44 
Mean psoas 
density 
0.18 0.16 0.95 0.75 
 
Table 3.  Univariate P-values assessing the association between morphometric 
measurements and outcomes.  Prolonged LOS: Length of Stay at least 7 days; 
Discharge to Care: Patient either discharged to another hospital for rehabilitation, or 
discharged to a care facility. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Survival Readmission-free 
survival 
Prolonged 
LOS 
Discharge 
to Care 
Subcutaneous 
fat 
0.009 
(HR 0.92  
95% CI 0.86-0.98) 
0.004 
(HR 0.96  
95% CI 0.93-0.99) 
0.40 0.35 
                                                                                                                                                        
Intra-abdominal 
fat 
0.39 
(HR 1.01 
95% CI 0.99-1.02) 
0.71 
HR 0.99  
95% CI 0.99-1.01) 
0.96 0.50 
Psoas muscle 
area 
0.18 
(HR 0.99 
95% CI 0.99-1.01) 
0.02 
(HR 1.00 
95% CI 1.00-1.01) 
0.84 0.10 
Mean psoas 
density 
0.27 
(HR 1.03 
95% CI 0.98-1.09) 
0.18 
(HR (0.98  
95% CI 0.95-1.01) 
0.13 0.85 
 
Table 4.  Multivariate P-values after confounder adjustment assessing the association 
between morphometric measurements and outcomes.  Prolonged LOS: Length of Stay 
at least 7 days; Discharge to Care: Patient either discharged to another hospital for 
rehabilitation, or discharged to a care facility. HR: Hazard ratios, CI: confidence 
intervals  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                        
 
 
 
 Intra-abdominal fat 
depth 
Psoas Muscle 
Area 
Psoas Muscle 
Mean Density 
Subcutaneous fat 
depth 
-0.04 0.09 0.04 
Intra-abdominal fat 
depth 
 0.55a -0.16b 
Psoas Muscle Area   0.02 
 
Table 5. Correlation between morphometric variable assessed in this patient cohort. a 
P = 1.2x10^{-14}; b P = 0.045 (Spearman Rank Correlation). 
 
 
 
